Participated · Seed · Mar 2022

Zephyr AI, based in McLean, Va., develops fast, explainable artificial intelligence and data-federation tools to advance precision medicine in oncology and cardiometabolic disease. The company is building improved data federation capabilities and machine learning algorithms and is deploying one of the largest clinicogenomic datasets spanning multiple disease states and data partners. Zephyr AI says it will use the new capital to enhance analytical speed and to fortify its training and validation datasets. The funds will also support expansion of the company’s scientific and commercial teams to accelerate delivery of its growing pipeline of insights to market. The team combines software engineers and biologists to generate translatable insights and build tools for patients, providers, and researchers. Zephyr AI has had two abstracts accepted for presentation at the AACR annual meeting in April 2024. Zephyr AI develops a proprietary suite of AI and data-science technologies that ingest complex, disparate healthcare data to generate translatable insights for precision medicine and drug discovery. The company emphasizes a three‑pronged approach: multi‑dimensional datasets, transparent AI, and analyses within structured biological networks and longitudinal outcomes. Since its founding in 2021 by Red Cell Partners, Zephyr has built a multidisciplinary team of data scientists, software engineers, and computational and molecular biologists. Zephyr prioritizes industry partnerships to access and maximally utilize broad healthcare datasets. The company aims to produce tools and products to support patients and providers, with focus areas including diabetes and cancer. Financially, Zephyr closed an $18.5 million seed round to expand dataset curation, refine machine‑learning models, and derive actionable insights for patient care and drug discovery.

Participated · Series A · Jul 2021

Axuall operates a workforce intelligence platform that aggregates clinician data through a national, real-time practitioner data network. Its Workforce Intelligence Network pulls clinician information from nearly 7,000 data sources and directly from physicians, advanced practice providers, and nurses via an integrated digital credential wallet with smart applications. The platform is used to reduce onboarding and enrollment time for healthcare systems, staffing firms, telehealth providers, and health plans while supplying data insights for network planning, analytics, and reporting. Axuall’s technology connects to the systems, vendors, and processes that customers already use. Led by co-founder and CEO Charlie Lougheed, the company has raised over $41M from more than two dozen healthcare organizations. It most recently announced an undisclosed Series B-1 that added Frist Cressey Ventures following a $20M Series B in May 2023. Axuall provides workforce intelligence powered by a national real-time practitioner data network, enabling healthcare systems, staffing firms, telehealth companies, and health plans to reduce onboarding and enrollment time while offering data insights for planning, analytics, and reporting. Led by CEO Charlie Lougheed, the company’s technology integrates with credentialing and recruiting workflows to streamline practitioner management. Axuall’s network today consists of over 6,800 primary data sources. The company recently raised $20M in a Series B to support growth. Axuall intends to use the funds to grow its product, sales, and marketing teams and to develop its data partnerships across its network. It also plans to accelerate API integration into planning, recruiting, credentialing, enrollment, CRM, and electronic medical record systems. Axuall operates a national digital professional identity network that enables clinicians, healthcare systems, staffing firms, telehealth groups, and health plans to share and manage authenticated provider credentials and qualifications in real time. Built on a provider-centric model, the network aims to eliminate onboarding delays, reduce physician burnout, and enable workforce intelligence across the healthcare industry. The solution was developed and piloted with University Hospitals, MedStar Health, and MetroHealth and launched commercially in late 2020. Axuall was formed in 2018 and initially raised $3 million of venture funding to develop the network. The company plans to use new capital to accelerate R&D, implementations, sales, and marketing as it grows its customer base of healthcare organizations. Management positions the product as addressing provider data delays and blind spots that drive billions in annual costs and care inefficiencies. Axuall operates a real-time digital network for verifying identity, credentials, and authenticity to eliminate waste, prevent fraud, and manage risk in healthcare, financial services, manufacturing, government, and other sectors. The network enables healthcare providers to request and receive digitally signed credentials from primary sources and securely share them with employers, health systems, and insurance plans. Axuall proactively monitors conditional events such as expirations and dependencies so practitioners can address issues as they arise, keeping credentials up-to-date and aligned with standards. Led by CEO Charlie Lougheed and based in Cleveland, OH, the company is preparing for commercial release. Axuall recently closed a $3M seed financing to support its near-term plans. The company intends to use the funds to hire additional software engineering and product personnel, run several large-scale pilots, develop its partner network, and complete R&D for commercial release.

Participated · Series A · Jul 2021

Truveta aggregates de-identified EHR data from a coalition of health systems into Truveta Data, a daily-updated, regulatory-grade dataset representing over 120 million patients. Launched in 2020, the company is a collaboration of some 30 health systems aligned on a mission to save lives with data. Its platform includes the Truveta Language Model, a large-language, multimodal AI model run on Microsoft Azure to normalize and transform billions of data points. Truveta is expanding into genotypic data through the Truveta Genome Project to link exomes and future multi-omics sequencing to clinical records. The combined genotypic and phenotypic database is intended for biopharma and academic research to accelerate drug discovery, optimize clinical trials, and train AI models. Data privacy and de-identification, along with Azure as the exclusive cloud provider for the genome project, are core operational elements described in the articles. Truveta collects privacy-safe, de-identified medical data from partner health systems and aggregates it for researchers. It partners with around 20 medical providers and ingests regular data from 42 states, aiming to build a living medical portrait of America. The company provides a software service that lets public-health researchers filter populations and drop into a Jupyter Notebook to build dashboards with data that updates daily. CEO Terry Myerson, formerly of Microsoft, says Truveta has its sights on 16% of all clinical care in the United States. Truveta has shared COVID-19 analyses from its platform, including findings that adverse events occur in fewer than 1% of fully vaccinated people and that Moderna patients showed 40% more events than Pfizer in their dataset. The company is not a nonprofit (it pays taxes), maintains an anti-advertising stance licensed for ethical medical research, and recently raised $100 million, bringing its capital base to around $200 million. Truveta operates a provider-led platform that brings together daily de-identified clinical data from its member health systems to deliver insights to clinicians and researchers. The platform aggregates tens of millions of patients and thousands of care facilities across 40 states and represents more than 15% of U.S. patient care. Truveta aims to help researchers find cures faster, empower clinicians with better data, and improve treatment and outcomes for diverse populations. The company emphasizes statistical representation across geography, race, ethnicity and other socioeconomic dimensions to address health disparities. Governance and investment come from its health system members, and earnings health providers receive from Truveta are intended to be reinvested into their communities. Truveta plans to hire technologists and health-data experts and invest in infrastructure and cloud-computing resources to build and scale the platform.

Participated · Series A · Nov 2017

Mytonomy offers a Cloud for Healthcare — a modular video-based patient engagement platform that combines 2,000+ broadcast-quality short-form videos with a new CRM to optimize healthcare content streaming and omnichannel engagement. The platform delivers video, audio, and written content that incorporates microlearning principles to drive patient usage and engagement. Mytonomy serves blue-chip healthcare customers and positions its tools across the entire care journey. The company is led by CEO and co-founder Anjali Kataria. Financially, Mytonomy announced a $25M Series B to support continued growth. The company intends to use the proceeds to expand its business reach. Mytonomy provides a cloud-based patient education, engagement and experience platform that leverages behavior science to support the care continuum. Its Patient Experience Cloud covers pre-arrival procedure preparation, in-patient admission, discharge instruction, at-home care and ambulatory clinic visits. The platform is designed to span multiple care settings to improve patient education and engagement across episodes of care. The company is led by CEO Anjali Kataria and President Vinay Bhargava. Mytonomy intends to use recent funding to accelerate market expansion of its Patient Experience Cloud. The company is based in Bethesda, Maryland. Mytonomy is an alumni-powered, video-based peer-to-peer college counseling service that connects high-school and college-bound students with alumni advisors through a video Q&A format. Launched in fall 2011 by Vinay Bhargava and Sean Burke, the platform targets users aged 14–25 and is used at over 100 high schools, with thousands of students having checked in. Individual students, college groups, educators and working professionals can use Mytonomy for free, while schools license premium features (Mytonomy Plus) at $5 per student per year for analytics and private video networks. The site emphasizes curated, guidance-focused video content to supplement overworked counselors and to provide first-generation and underprivileged students access to alumni perspectives. Mytonomy is expanding into new languages, starting with Spanish, and is considering incentive structures for volunteer contributors to boost participation and quality. The company used part of an early $250K funding package to roll out a new user interface to improve the site's user experience.